Serum Institute of India received approval to start human trials for Oxford vaccine
On Aug. 1, 2020, the Serum Institute of India (SII) got the approval to start human trials in…
-
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the National Institutes of Health (NIH) announced that it had invested $248.7 million in…
-
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
-
NIH researchers discovered new set of channels connecting malaria parasite and blood cells
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
-
Experimental COVID-19 vaccine protected upper and lower airways in nonhuman primates
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
-
Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 Vaccine candidate
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
-
NIH awarded $9.5 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccines
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
-
Kidney transplantation between people with HIV is safe, NIH study found
On Jul. 23, 2020, kidney transplantation from deceased donors with HIV to people living with both HIV and…
-
Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
-
NIH leadership detailed unprecedented initiative to ramp up testing technologies for COVID-19
On Jul. 22, 2020, In a paper in the New England Journal of Medicine, scientific leaders from the…
-
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVID single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmune’s single-dose intranasal vaccine…
-
Biology | Biotechnology | Diagnostics | Imaging | Neurology | NIH | Women's Health
NIH study showed highly reproducible sex differences in aspects of human brain anatomy
On Jul. 20, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…
-
The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testing
On Jul. 18, 2020, the U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to…
-
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
On Jul. 14, 2020, a study by National Institutes of Health (NIH) researchers reported the placental membranes that…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH researchers generated complete human X chromosome sequence
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes…
-
Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVID
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
-
NIH researchers reframed dog-to-human aging comparisons
On Jul. 9, 2020, a study, published in the journal Cell Systems, laid out a new framework for…
-
Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVID
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
-
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers formed collaboration to develop Emergent’s COVID-19 hyperimmune globulin product
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
-
USDA announced an initial purchase of vaccine for National Animal Vaccine and Veterinary Countermeasures Bank
On Jul. 8, 2020, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS)…
-
Biotechnology | Diagnostics | Neurology | NIH
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 8, 2020, a study from the National Institutes of Health (NIH) showed that neurofilament light chain…
-
Biotechnology | HIV | NIH
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
-
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | Influenza | Vaccine
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the U.S. Food and Drug Administration (FDA) announced it had issued an emergency use…
-
Ignoring airborne COVID spread risky
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
-
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnson’s COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
